ABBV

NYSE · Biotechnology

Abbvie Inc

S&P 500 Mega-Cap Stocks Blue Chip Stocks Biotech Stocks Healthcare Stocks Best Dividend Stocks Highest Dividend Yield

$265.21

+0.73 (+0.28%)

As of Sep 22, 9:30 PM ET ·

Analyst Consensus

Strong Buy

Analysts

Very High

Coverage

Buy 32 82%

Hold 7 18%

Sell 0 0%

Price Target

Analyst Price Target -2.9% upside

Low Target $173.19

Average Target $257.58

High Target $337.66

Current Price $265.21

Current
$265.21

Target
$257.58

$173.19 $257.58 avg $337.66

Scenario Analysis

Bear Case

$173.19

-34.7%

Low target

Base Case

$257.58

-2.9%

Avg target

Bull Case

$337.66

+27.3%

High target

Risk/Reward

0.8x

Unfavorable

Price in Context

52-Week High

$267.47

-0.8% from high

52-Week Low

$190.75

+39.0% from low

50-Day SMA

$223.82

+18.5% vs SMA

200-Day SMA

$211.12

+25.6% vs SMA

RSI (14)

54.5

Neutral

Target vs 52W High

$257.58

-3.7% vs high

Peer Consensus — Biotechnology

Stock	Consensus	Analysts	Buy %	Target	Upside
ABBV Abbvie Inc	Strong Buy	39	82%	$257.58	-2.9%
AMGN Amgen Inc	Hold	43	47%	$190.87	-53.5%
GILD Gilead Sciences Inc	Strong Buy	37	81%	$362.68	+137.6%
VRTX Vertex Pharmaceuticals Inc	Strong Buy	36	81%	$438.34	-14.9%
REGN Regeneron Pharmaceuticals	Buy	38	68%	$76.80	-90.4%
MRNA Moderna Inc	Hold	30	37%	$149.45	-18.1%
NTRA Natera Inc	Strong Buy	30	87%	$142.91	-63.4%
RVMD Revolution Medicines Inc	Strong Buy	28	93%	$114.11	-40.8%